Metabolomics Services Market Report 2026

Metabolomics Services Market Overview

• Metabolomics Services market size has reached to $3.04 billion in 2025 • Expected to grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 14.4% • Growth Driver: Rising Demand For Personalized Medicine Boosts Metabolomics Services Market Growth • Market Trend: Innovative Diagnostic Tools Transform Metabolomics With Focused Biomarker Panels • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Metabolomics Services Market?

Metabolomics services refer to the analytical and technological processes used to study the metabolites within a biological system. Metabolites are small molecules that are the end products of cellular processes, and their analysis provides a snapshot of the physiological state of an organism. It is used to study disease mechanisms, identify biomarkers, and improve drug development and personalized medicine. The main types of metabolomics services are untargeted metabolomics services and targeted metabolomics services. Untargeted metabolomics services involve a comprehensive analysis of all detectable metabolites in a biological sample without predefined targets. The various products and services include metabolomics bioinformatics services, chromatography, mass spectrometry, and others and are used by several end-users such as agriculture and food, biomedical and pharmaceutical, academic and research labs, diagnostic laboratories, and others.

What Is The Metabolomics Services Market Growth Forecast?

The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine research, rising demand for high-throughput metabolomics services, expansion of precision drug discovery programs, growing focus on systems biology approaches, increasing use of ai-driven data analytics. Major trends in the forecast period include increasing demand for outsourced metabolomics analysis, growing use of untargeted metabolomics services, expansion of biomarker discovery programs, rising integration of advanced bioinformatics tools, enhanced focus on drug development applications.

What Is The Driver Of The Metabolomics Services Market?

The increasing demand for personalized medicine is expected to propel the growth of the metabolomics services market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic makeup, environmental factors, and lifestyle. The increasing demand for personalized medicine is driven by advancements in genomic technologies, enabling more precise and tailored treatments and a growing emphasis on individualized patient care for better outcomes. Metabolomics services enhance personalized medicine by providing detailed metabolic profiles that help tailor treatments to individual patients' unique biochemical states, leading to more effective and targeted therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US based government organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, increasing demand for personalized medicine drives the growth of metabolomics services.

Key Players In The Global Metabolomics Services Market

Major companies operating in the metabolomics services market are Metabolon Inc., Biocrates Life Sciences AG, Nightingale Health, Human Metabolome Technologies Inc., MS-Omics, Creative Proteomics, Stemina Biomarker Discovery Inc., Metware Biotechnology Co. Ltd., OWL Metabolomics, BGI Metabolomics, MSDIAL Services, Chenomx Inc., BioMark Diagnostics, Microbiome Insights, Phenome Centre Birmingham, Australian National Phenome Centre, Biosfer Teslab, The Metabolomics Innovation Centre, One Way Liver Genomics, Revvity Omics Services

Global Metabolomics Services Market Trends and Insights

Major companies operating in the metabolomics services market are developing innovative diagnostic tools, to enhance disease detection and personalized medicine. Diagnostic tools are instruments and methods used to identify and assess medical conditions, diseases, or health issues, helping healthcare professionals make accurate diagnoses and guide treatment decisions. For instance, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology company, launched target metabolite and lipid panels for biomarker discovery and rapid time-to-insight. The panels offer a focused approach to identifying and quantifying specific metabolites and lipids, which enhances the precision of biomarker detection. These panels are designed for rapid time-to-insight, enabling quick turnaround of results, which is crucial for timely decision-making in research and clinical settings. These panels include advanced data analysis tools to interpret complex metabolic profiles and provide actionable insights.

What Are Latest Mergers And Acquisitions In The Metabolomics Services Market?

In June 2025, Bruker Corporation, a US-based scientific instruments and life sciences company, acquired Biocrates Life Sciences AG for an undisclosed amount. Through this acquisition, Bruker aims to enhance its multiomics strategy by integrating Biocrates’ mass spectrometry (MS)-based metabolomics kits, assays, software, and research services, thereby expanding its capabilities in quantitative metabolite and lipid analysis. Biocrates Life Sciences AG is an Austria-based manufacturing company that provides standardized MS-based metabolomics solutions, including kits capable of quantifying up to 1,881 biomarkers from a single sample, supporting laboratories worldwide in drug development, biomarker discovery, and precision healthcare.

What Defines the Metabolomics Services Market?

The metabolomics services market includes revenues earned by entities through metabolite identification, custom assay development, and metabolic profiling, and related nuclear magnetic resonance (NMR) spectroscopy systems, sample preparation kits, biomarker panels, and analytical platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Metabolomics Services Market Report 2026?

The metabolomics services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.